Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-13
DOI
10.1007/s40257-021-00610-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies
- (2021) Kim Papp et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Effects of Ruxolitinib Cream on Pruritus and Quality of Life in Atopic Dermatitis: Results From a Phase 2, Randomized, Dose-Ranging, Vehicle- and Active-Controlled Study
- (2020) Brian S. Kim et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- New and Emerging Systemic Treatments for Atopic Dermatitis
- (2020) Megan Newsom et al. DRUGS
- JAK/STAT inhibitors for the treatment of atopic dermatitis
- (2019) Maria Alexandra Rodrigues et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream
- (2019) Brian S. Kim et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- (2019) Michael D. Howell et al. Frontiers in Immunology
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- (2019) Farzan Solimani et al. Frontiers in Immunology
- Patient-burden and quality of life in atopic dermatitis in US adults: A population-based cross-sectional study
- (2018) J.I. Silverberg et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Efficacy and safety of topical JTE-052, a Janus kinase inhibitor, in Japanese adult patients with moderate-to-severe atopic dermatitis: a phase II, multicentre, randomized, vehicle-controlled clinical study
- (2018) H. Nakagawa et al. BRITISH JOURNAL OF DERMATOLOGY
- Patient impact and economic burden of mild to moderate atopic dermatitis
- (2018) Adelaide A. Hebert et al. CURRENT MEDICAL RESEARCH AND OPINION
- Phase 1 studies to assess the safety, tolerability and pharmacokinetics of JTE-052 (a novel Janus kinase inhibitor) ointment in Japanese healthy volunteers and patients with atopic dermatitis
- (2018) Hidemi Nakagawa et al. JOURNAL OF DERMATOLOGY
- Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
- (2018) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A practical algorithm for topical treatment of atopic dermatitis in the Middle East emphasizing the importance of sensitive skin areas
- (2018) Ashraf M. Reda et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Systemic Tofacitinib Concentrations in Adult Patients With Atopic Dermatitis Treated With 2% Tofacitinib Ointment and Application to Pediatric Study Planning
- (2018) Vivek S. Purohit et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population
- (2018) Zelma C. Chiesa Fuxench et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies
- (2017) Patrick M. Brunner et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Analyzing the Potential Root Causes of Variability of Pharmacokinetics in Preclinical Species
- (2017) Pierre Daublain et al. MOLECULAR PHARMACEUTICS
- Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial
- (2016) R. Bissonnette et al. BRITISH JOURNAL OF DERMATOLOGY
- Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016
- (2016) Hidehisa Saeki et al. JOURNAL OF DERMATOLOGY
- Sleep Disturbances in Adults with Eczema Are Associated with Impaired Overall Health: A US Population-Based Study
- (2015) Jonathan I. Silverberg et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
- (2015) Lauren L. Levy et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Targeting key proximal drivers of type 2 inflammation in disease
- (2015) Namita A. Gandhi et al. NATURE REVIEWS DRUG DISCOVERY
- Is Adult Atopic Eczema More Common Than We Think? – A Population-based Study in Danish Adults
- (2014) G Vinding et al. ACTA DERMATO-VENEREOLOGICA
- Associations of Childhood Eczema Severity
- (2014) Jonathan I. Silverberg et al. Dermatitis
- Guidelines of care for the management of atopic dermatitis
- (2014) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis
- (2013) F. Cervantes et al. BLOOD
- Population Pharmacokinetic Analysis of Orally-Administered Ruxolitinib (INCB018424 Phosphate) in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET MF)
- (2013) Xuejun Chen et al. JOURNAL OF CLINICAL PHARMACOLOGY
- The Global Burden of Skin Disease in 2010: An Analysis of the Prevalence and Impact of Skin Conditions
- (2013) Roderick J. Hay et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Guidelines of care for the management of atopic dermatitis
- (2013) Lawrence F. Eichenfield et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Eczema among adults: prevalence, risk factors and relation to airway diseases. Results from a large-scale population survey in Sweden
- (2012) E.P. Rönmark et al. BRITISH JOURNAL OF DERMATOLOGY
- Preliminary clinical activity of a topical JAK1/2 inhibitor in the treatment of psoriasis
- (2012) Naresh Punwani et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
- (2012) J. Ring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Guidelines for treatment of atopic eczema (atopic dermatitis) Part I
- (2012) J. Ring et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis
- (2012) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Pharmacokinetics, Pharmacodynamics, and Safety of Orally Dosed INCB018424 Phosphate in Healthy Volunteers
- (2011) Jack G. Shi et al. JOURNAL OF CLINICAL PHARMACOLOGY
- From atopic dermatitis to asthma: the atopic march
- (2010) Jonathan M. Spergel ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms
- (2010) A. Quintas-Cardama et al. BLOOD
- Epidemiology of Atopic Dermatitis and Atopic March in Children
- (2010) Jonathan M. Spergel IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three
- (2009) Joseph A. Odhiambo et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Guidelines for management of atopic dermatitis
- (2009) Hidehisa SAEKI et al. JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now